How much funding has Myriad Genetics raised?

Myriad Genetics has raised $190.0M in total funding, most recently a Venture Round.

Who are Myriad Genetics's investors?

Myriad Genetics's investors include Bank of America, Wells Fargo, JPMorgan Chase.

When was Myriad Genetics founded?

Myriad Genetics was founded in 1991.

Where is Myriad Genetics headquartered?

Myriad Genetics is headquartered in Salt Lake City, Utah, United States.

What industry is Myriad Genetics in?

Myriad Genetics operates in Biotech, Healthcare.

How many employees does Myriad Genetics have?

Myriad Genetics has 1001-5000 employees.

Myriad Genetics

IPO

Genetic Testing | Advancing Health with Myriad Genetics

Public · Salt Lake City, United States · Founded 1991 · $190.0M raised

Biotech

Healthcare

Headquarters: Salt Lake City, Utah
Employees: 1001–5000
Founded: 1991
Business Model: B2B2C
Website: myriad.com

Total Funding: $190.0M
Last Round: $100.0M Venture RoundNov 2023
Rounds: 2
Type: Public

About

Myriad Genetics is a leading genetic testing company founded in 1991, offering hereditary cancer, prenatal, oncology, and mental health genetic tests to help patients and clinicians detect, treat, and prevent disease. Its flagship MyRisk Hereditary Cancer Test screens 25 genes associated with significantly elevated cancer risk, serving patients, families, and healthcare providers worldwide.

Summary

Myriad Genetics is a Biotech company based in Salt Lake City, United States, founded in 1991. It has raised $190.0M in total across 2 rounds, most recently a $100.0M Venture Round round in Nov 2023. Investors include Bank of America, Wells Fargo and JPMorgan Chase.

LinkedIn X (Twitter)GitHub